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Abstract: Activation of the cAMP pathway is an important mediator of chronic 
muscle pain. This study examined phosphorylation of the transcription factor 
cAMP-response-element-binding protein (p-CREB) and the NR1 subunit of the 
NMDA receptor (p-NR1) in the spinal cord. Bilateral mechanical hyperalgesia 
of the paw was induced by administering two injections of acidic saline, 5 d 
apart, into the gastrocnemius muscle of male Sprague Dawley rats. The 
proportion of spinothalamic neurons that expressed p-NR1 or p-CREB did not 
change in the dorsal horn 24 hours after the second intramuscular acid 
injection compared with animals that received pH 7.2 injections. This lack of 
change in spinothalamic neurons in the dorsal horn may be due to increases 
in individual spinothalamic neurons or increases in non-spinothalamic 
neurons. There was an increase in the proportion of spinothalamic neurons 
expressing p-NR1 in lamina X. These findings suggest that there are region-
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specific changes in spinothalamic neurons that express p-NR1 and lamina X 
may play an important role in the modulation of chronic muscle pain. 
Keywords: cAMP pathway, protein kinase A, phosphorylation, nociception 
Introduction 
Activation of the cAMP pathway has an integral role in 
nociceptive processing. Spinal activation of the cAMP pathway 
produces mechanical hyperalgesia and increases the response of 
spinothalamic tract neurons to noxious but not innocuous mechanical 
stimuli [12, 16, 17]. Mice lacking adenylate cyclases 1 and 8 have no 
changes in acute pain but have decreases in behavioral responses 
after administration of formalin, complete Freund’s adjuvant (CFA), 
and intramuscular carrageenan [20, 21]. Furthermore, blocking 
adenylate cyclase or protein kinase A (PKA) prevents the mechanical 
hyperalgesia and allodynia produced by intradermal, intramuscular, or 
intraarticular injection of capsaicin, and repeated intramuscular acidic 
saline injections [9, 17, 19]. 
The catalytic subunit of PKA translocates to the nucleus and 
phosphorylates cAMP-response-element-binding protein (CREB) at 
serine-133, which is necessary for gene transcription. An increase in 
phosphorylated-CREB (p-CREB) occurs in a number of pain models 
such as carrageenan paw inflammation[13], intradermal capsaicin 
[22], subcutaneous formalin [10, 21], nerve growth factor [7], 
neuropathic pain [14], and repeated intramuscular acid injections [9]. 
Furthermore, p-CREB corresponds to the time frame of hyperalgesia in 
neuropathic and inflammatory pain [10, 14], and there is an 
upregulation of p-CREB in spinothalamic neurons after spinal cord 
injury [4]. Thus, phosphorylation of CREB is involved in central 
nervous system changes associated with hyperalgesia. 
PKA also phosphorylates the NMDA receptor at serine-897 of the 
NR1 subunit (p-NR1). Protein kinases functionally modulate the NMDA 
receptor through phosphorylation. Specifically, phosphorylation by 
intracellular messengers promotes receptor trafficking and alter cell 
kinetics. Similar to p-CREB, there are increases in p-NR1 in several 
animal models of nociception: intradermal capsaicin [24, 25], 
neuropathic [6], and carrageenan paw inflammation [3]. Following 
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intradermal capsaicin, p-NR1 increases in nociceptive specific neurons 
and this increase is prevented by blocking PKA [24, 25]. Following 
excitotoxic spinal cord injury, excessive grooming is associated with 
phosphorylation of NR1 [3]. Thus, phosphorylation of the NMDA 
receptor by PKA is an important mediator of pain transmission. 
We have previously shown that increases in p-CREB and 
mechanical hyperalgesia in a chronic muscle-induced hyperalgesia 
model are dependent on activation of the cAMP pathway [9]. 
Specifically, there is a time-dependent increase in the density of 
immunoreactivity for p- CREB. This increase could represent an 
increase in the amount of p-CREB or number of cells expressing p-
CREB. The purpose of this study is to determine if there is an increase 
in the number of spinothalamic neurons that express p-CREB or p-NR1 
following chronic muscle-induced hyperalgesia. We hypothesize there 
will be an increase in the number of spinothalamic neurons that 
express p-CREB and p-NR1. 
Methods 
All methods were approved by the University of Iowa’s Animal 
Care and Use Committee and followed the policies issued by the 
International Association for the Study of Pain and National Institutes 
of Health on the use of laboratory animals. Male Sprague Dawley rats 
were used in all of the experiments (250–350 g; Harlan, St. Louis, 
MO). 
Chronic Muscle-Induced Hyperalgesia Model 
Two injections of pH 4.0 sterile saline (100 μl) were 
administered five days apart in the left gastrocnemius muscle while 
the rats were anesthetized with vaporized halothane (2–4%) [18]. This 
model produces long-lasting bilateral mechanical hyperalgesia with 
minimal to no muscle tissue damage or motor deficits [18]. In some 
animals, two intramuscular injections of pH 7.2 (100 μl) sterile saline 
were used for controls. 
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Fluorogold Injections into Thalamus 
Fluorogold injections into the thalamus were performed to co-
localize spinothalamic neurons with either p-CREB or p-NR1. Rats were 
anesthetized with Nembutal (50 mg/kg, i.p.) and placed in a 
stereotactic frame for thalamic injections. Four injections of 2% 
fluorogold (1 μl total) were given on each side (ipsilaterally and 
contralaterally) into the thalamus using a Hamilton microsyringe based 
on coordinates from The Rat Brain in Stereotactic Coordinates [15]. 
Thalamus injections were verified for accurate placement by sectioning 
the rat’s thalamus using a cryostat and mapping the injection sites. 
Co-localization of Spinothalamic Neurons with p-CREB 
or p-NR1 
Rats were anesthetized with sodium pentobarbital (100 mg/kg, 
i.p.) and perfused through the left ventricle with 100 ml of heparinized 
saline followed by 1 liter of 4% paraformaldehyde in 0.1 M phosphate 
buffer (PB), pH 7.4, 4°C. The L5 segment was removed and placed in 
30% sucrose solution. Tissue was cut, using a cryostat, into 40 μm 
sections and placed in PB. Sections were alternately placed in the p-
NR1 or p-CREB vial to ensure that profiles were not counted more than 
once for each antibody. These sections were exposed to a number of 
solutions in a step-wise procedure that included 0.5% H202, 1% 
NaBorohydride, solution A (Avidin), solution B (Biotin) and 3% normal 
goat serum. Between each step, tissue was rinsed in phosphate 
buffered saline (PBS). Next, sections were incubated overnight in 
primary antibody in 1% normal goat serum/PBS 0.75% Triton X 100 at 
room temperature as follows: anti-p-CREB (1:2000; goat anti-rabbit; 
Upstate Biotechnology) or anti-p-NR1 (1:10,000; goat anti-rabbit; 
Upstate Biotechnology). Preliminary dilution series were conducted to 
determine appropriate concentrations for p-NR1, p-CREB, and 
fluorogold antibodies. 
Following overnight incubation, sections were washed in PBS 
and 3% normal goat serum followed by incubation for 1h in the 
secondary antibody biotinylated-goat anti-rabbit IgG (1:1000). After 
washing in PBS and 3% normal goat serum, sections were incubated in 
Avidin-HRP (1% normal goat serum with 0.75 Triton X 100) (1:1000) 
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for 1h. This step was followed by 6 minutes in nickel-enhanced DAB 
(Vector Laboratories, Inc., Burlingame, CA). To decrease cross 
reaction between the two antibodies, tissue was rinsed in PBS six 
times and once in 1% formalin/PB solution. The day 1 protocol was 
repeated except the tissue was placed in anti-fluorogold antibody, 
which was raised in rabbit, (1:200,000, Fluorochrome, Inc) and 
incubated overnight. 
On the third day of labeling, sections were washed in PBS and 
3% normal goat serum followed by incubation for 1h in the secondary 
antibody biotinylated-goat anti-rabbit IgG (1:1000). After washing in 
PBS and 3% normal goat serum, sections were incubated in Avidin-
HRP (1% normal goat serum with 0.75 Triton X 100) (1:1000) for 1h. 
This step was followed by 6 minutes in DAB (Vector Laboratories, Inc., 
Burlingame, CA). Sections were washed and mounted on slides, 
allowed to dry 24–48 hours prior to cleaning in ethanol/water and 
propar and coverslipped. 
Counting Profiles 
Spinal cord sections were randomly chosen from each rat. 
Images were generated using an Olympus BX-51 microscope (Central 
Electron Microscopy Research Facility, University of Iowa). For co-
localization of p-NR1 or p-CREB with spinothalamic neurons, positively 
double labeled profiles were counted in the following areas: lamina I, 
deep dorsal horn (laminae III–VI), lamina X, and ventral horn. 
Approximately 17–25 segments were counted for each animal. The 
majority of retrogradely labeled spinothalamic neurons were in the 
deep dorsal horn, approximately 100 cells per animal, compared to the 
average of 10 cells per animal in the superficial dorsal horn; thus 
explaining the variability in the co-localization. The proportion of 
spinothalamic neurons co-localized with p-NR1 or p-CREB were 
analyzed using a one-way ANOVA. Level of statistical analysis 
significance was set at p < 0.05. 
Experimental Design 
Fluorogold was injected bilaterally into the rat thalamus. Rats 
were allowed to recover three days. Following the recovery period, 
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hyperalgesia was induced by administering two pH 4.0 saline injections 
into the left gastrocnemius given five days apart. Twenty-four hours 
following the second injection, immunohistochemistry was performed 
to identify spinothalamic neurons that contained either p-NR1 or p-
CREB. This procedure was repeated using a control group of animals 
that received two pH 7.2 intramuscular injections. Quantification was 
determined by counting the number of spinothalamic neurons 
expressing p-NR1 or p-CREB. Eleven animals were used to complete 
this study. 
Results 
Spinothalamic Neurons Express p-CREB 
Spinothalamic neurons co-localized with p-CREB (Fig. 1). 
Animals that received pH 4.0 intramuscular acid injections presented 
with the following proportion of spinothalamic neurons that expressed 
p-CREB 24 hours after the second intramuscular acid injection in 
lamina X (32%), ipsilaterally in lamina I (68%), deep dorsal horn 
(23%), and ventral horn (19%), and contralaterally in lamina I (60%), 
deep dorsal horn (24%), and ventral horn (25%) (Fig. 2). Animals that 
received pH 7.2 intramuscular acid injections presented with the 
following proportion of spinothalamic neurons co-localized with p-CREB 
in lamina X (50%), ipsilaterally in lamina I (79%), deep dorsal horn 
(23%), and ventral horn (15%), and contralaterally in lamina I (86%), 
deep dorsal horn (26%), and ventral horn (8%) (Fig. 2). The number 
of spinothalamic neurons that expressed p-CREB remained unchanged 
in the spinal cord 24 h after the second intramuscular injection of pH 
4.0 saline compared with animals that received pH 7.2 intramuscular 
injections (Fig. 2). Specifically, co-localization of spinothalamic 
neurons with p-CREB did not significantly differ in lamina X (p= 0.30), 
ipsilaterally in lamina I (p= 0.42), deep dorsal horn (p= 0.99), and 
ventral horn (p= 0.82), and contralaterally in lamina I (p= 0.06), deep 
dorsal horn (p= 0.66), and ventral horn (p= 0.38) compared with rats 
that received pH 7.2 intramuscular injections. Repeated intramuscular 
acid injections did not induce changes in the co-localization of 
spinothalamic neurons with p-CREB. 
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Figure 1 Spinothalamic neuron expressing p-CREB 
DAB labeling of spinothalamic tract neurons (brown arrows), nickel-enhanced DAB 
labeling for p-CREB (black arrows), and co-localization of pCREB and spinothalamic 
tract neurons (white arrows). B and C are higher power magnifications of the areas 
outlined in A. 
 
 
 
Figure 2 Proportion of spinothalamic neurons expressing p-
CREB at 24 hours 
The proportion of p-CREB profiles co-localized with spinothalamic neurons is shown for 
animals that received two intramuscular injections of acidic saline (black bars) and for 
those that received two intramuscular injections of pH 7.2 saline (open bars). Co-
localization was similar between different lamina (lam), and between the ipsilateral 
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and contralateral sides. There was no significant difference in the proportion of 
retrogradely labeled spinothalamic neurons with p-CREB in the spinal cord 24 h after 
the second intramuscular injection of pH 4.0 saline compared with pH 7.2 
intramuscular injections. Data are presented as the average with the standard error of 
the mean. 
The pH 4.0 and pH 7.2 injected animals were combined due to 
the insignificance between pH 4.0 and pH 7.2 injected animals. The 
number of spinothalamic neurons that expressed p-CREB in pH 4.0 
and pH 7.2 injected animals was greater in lamina I ipsilaterally (p < 
0.014) and contralaterally (p < 0.016) compared with the deep dorsal 
horn, ventral horn, and lamina X. 
Spinothalamic Neurons Express p-NR1 
Spinothalamic neurons co-localized with p-NR1 (Fig. 3). Animals 
that received pH 4.0 intramuscular acid injections presented with the 
following proportion of spinothalamic neurons co-localized with p-NR1 
in lamina X (93%), ipsilaterally in lamina I (98%), deep dorsal horn 
(84%), and ventral horn (73%), and contralaterally in lamina I (79%), 
deep dorsal horn (82%), and ventral horn (53%) (Fig. 4). Animals that 
received pH 7.2 intramuscular acid injections presented with the 
following proportion of spinothalamic neurons co-localized with p-NR1 
in lamina X (76%), ipsilaterally in lamina I (96%), deep dorsal horn 
(81%), and ventral horn (88%), and contralaterally in lamina I (79%), 
deep dorsal horn (74%), and ventral horn (80%) (Fig. 4). Co-
localization of spinothalamic neurons with p-NR1 did not significantly 
differ ipsilaterally in lamina I (p= 0.72), deep dorsal horn (p= 0.72), 
and ventral horn (p= 0.27), and contralaterally in lamina I (p= 0.97), 
deep dorsal horn (p= 0.33), and ventral horn (p= 0.23) compared 
with rats that received pH 7.2 intramuscular injections. The number of 
spinothalamic neurons that expressed p-NR1 was significantly greater 
in lamina X (p= 0.03) 24 hours after the second intramuscular 
injection of pH 4.0 saline compared with rats that received pH 7.2 
injections (Fig. 4). 
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Figure 3 Spinothalamic neuron expressing p-NR1 
DAB labeling of spinothalamic tract neuron (brown arrow), nickel-enhanced DAB 
labeling for p-NR1 (black arrows), and co-localization pNR1 and spinothalamic tract 
neurons (white arrows). B is a high power magnification of the area outlined in A 
showing a spinothlamic tract cell labeled for pNR1. C is a high power magnification of a 
spinothalamic tract cell that is not labeled with pNR1. 
 
 
Figure 4 Proportion of spinothalamic neurons expressing p-
NR1 at 24 hours 
The proportion of p-NR1 profiles co-localized with spinothalamic neurons is shown for 
animals that received two intramuscular injections of acidic saline (black bars) and for 
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those that received two intramuscular injections of pH 7.2 saline (open bars). Over 
80% of spinothalamic tract neurons co-localized with p-NR1. There was an increase in 
the number of co-localized neurons in lamina X of the spinal cord, but not in the 
superficial laminae (lam I), the deeper dorsal horn (lam III–VI), or the ventral horn, 
for the animals injected with pH 4.0 saline compared with those injected with pH 7.2 
saline. Data are presented as the average with the SEM *, p < 0.05. 
Discussion 
Spinothalamic Neurons and p-CREB 
This study demonstrates that p-CREB co-localizes with 
spinothalamic neurons throughout the spinal cord. The proportion of 
pH 4.0 and pH 7.2 spinothalamic neurons expressing p-CREB was 
greater in lamina I bilaterally compared with deep dorsal horn, ventral 
horn and lamina X. Approximately 60% of lamina I spinothalamic 
neurons were positive for p-CREB compared with ~20% in the deep 
dorsal horn. Thus, lamina differences may be important for processing 
nociceptive specific changes involved in gene transcription. 
Previously we demonstrated increases in the density of p-CREB 
in the chronic muscle pain model, which correlated with the 
mechanical withdrawal threshold [9]. This study shows that there was 
not an increase in the number of spinothalamic neurons expressing p-
CREB, therefore activation of the cAMP pathway likely increases the 
phosphorylation of CREB in individual spinothalamic neurons or 
increases the proportion of non- spinothalamic neurons expressing p-
CREB. For example, following sciatic nerve transaction, the number of 
glial cells expressing CREB increased in the lumbar spinal cord [8]. 
In contrast to our findings, Crown and colleagues demonstrated 
an increase in the proportion of spinothalamic neurons that expressed 
p-CREB in a spinal cord injury model [4]. All of the spinothalamic 
neurons in the spinal cord injured rats expressed p-CREB, which 
correlated with tactile allodynia, compared with 64% of the neurons in 
the sham rats [4]. These findings indicate that chronic muscle pain 
and neuropathic pain likely have subtle differences in how activation of 
the cAMP pathway modulates pain transmission. 
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Spinothalamic Neurons and p-NR1 
This study demonstrates that the majority of spinothalamic 
neurons express p-NR1. The proportion of spinothalamic neurons that 
express p-NR1 did not change in the dorsal horn 24 hours after the 
second intramuscular acid injection compared with animals that 
received pH 7.2 injections. This lack of change in p-NR1 is unlike 
previous studies demonstrating increases in the proportion of 
spinothalamic neurons expressing p-NR1 following an intradermal 
capsaicin injection [24, 25]. This increase in expression of p-NR1 in 
neurons was prevented in the superficial laminae (I–III), but not 
deeper laminae (IV–VII), by pretreatment with a PKA inhibitor [24, 
25]. 
Interestingly, there was an increase in the proportion of 
spinothalamic neurons expressing p-NR1 in lamina X 24 hours after 
the second intramuscular acid injection. The increase in lamina X is 
surprising. Willis and colleagues did not quantify the proportion of 
spinothalamic neurons expressing p-NR1 in lamina X [24, 25]. 
However, they did indicate that spinothalamic neurons expressing p-
NR1 were present in lamina X [24]. Therefore, the change in lamina X 
is difficult to compare with the previous literature on spinothalamic 
neurons expressing p-NR1, which may or may not be specific to 
muscle pain. 
Previous literature supports the role of lamina X in a number of 
acute and chronic pain conditions including visceral, inflammatory and 
muscle [1, 5, 11]. For example, following noxious visceral stimulation 
the expression of immediate early genes in spinal cord neurons 
increased, which included lamina X [11]. In sheep with footrot, alpha2 
-adrenoreceptor binding increased in lamina I, II, and X [1]. 
Furthermore, the proportion of neurokinin-1 neurons expressing Fos 
was greater following intramuscular injection of mustard oil compared 
with mustard oil topically applied to the rat hindpaw in laminae V–X 
[5]. Thus, changes in lamina X demonstrated in the chronic muscle 
pain model reflect changes expressed in other pain models. 
Neurons from lamina X send and receive projections 
supraspinally. Furthermore, descending projections from supraspinal 
sites, such as the RVM, release serotonin in the spinal cord. Serotonin 
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receptors in the spinal cord mediate descending facilitation [2, 23]. 
Thus, descending facilitatory pathways, which send projections to 
lamina X, mediate hyperalgesia potentially by releasing serotonin and 
activating the cAMP pathway. Similarly, in the chronic muscle pain 
model, descending facilitatory pathways may activate the cAMP 
pathway and regulate mechanical hyperalgesia. 
One of the limitations in this experiment is the high proportion 
of spinothalamic neurons expressing p-NR1 in the dorsal horn of the 
control group that received two pH 7.2 intramuscular injections. Thus, 
increases following repeated intramuscular acid injections would be 
difficult to obtain significance. This particular protocol may not be 
sensitive enough to record changes in the expression of p-NR1 in 
spinothalamic neurons in the dorsal horn. 
Conclusion 
The expression of p-CREB did not change in spinothalamic tract 
neurons. Due to the use of density readings to measure the increase in 
spinal p-CREB in this chronic muscle pain model [9], this lack of 
change in spinothalamic neurons may be due to increases in individual 
spinothalamic neurons or increases in non-spinothalamic neurons, 
such as glial cells, thus suggesting a number of possibilities for future 
studies. 
Similarly, there was no change in the dorsal horn in the 
proportion of spinothalamic neurons expressing p-NR1. These results 
are unlike previous literature that demonstrates an increase in the 
proportion of spinothalamic neurons expressing p-NR1 or p-CREB in an 
inflammatory cutaneous pain model or neuropathic pain model, 
respectively [4, 24, 25]. Therefore, this lack of change in p-NR1 and p-
CREB in the dorsal horn may be specific to chronic muscle pain. 
Surprisingly, there was an increase in the proportion of 
spinothalamic neurons expressing p-NR1 in lamina X. There is difficulty 
in comparing this increase with previous literature since lamina X was 
not measured. Hence, the increase in proportion of spinothalamic 
neurons expressing p-NR1 in chronic muscle pain is an exciting 
discovery potentially indicating region-specific changes. 
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